Featured Non-Traditional Income: Strategies for a Rising Rate Environment By Max ChenFebruary 2, 2022
Alternatives Channel Merger Arbitrage as an Alternative Investment Strategy By Elle CarusoJanuary 25, 2022
ETF Building Blocks Channel Consolidation Could Come Calling for Biotech in 2022 By Tom LydonJanuary 5, 2022
ETF Building Blocks Channel Memeification of Biotech Stocks Shines Light on This ETF By Tom LydonNovember 24, 2021
ETF Building Blocks Channel Biotech Ready to Participate in Healthcare Bullishness By Tom LydonOctober 29, 2021
ETF Building Blocks Channel Drug Price Debate May Not Hinder Biotech ETFs After All By Tom LydonSeptember 16, 2021
ETF Building Blocks Channel Biotech Stocks Have Colds, but They Can Heal By Tom LydonSeptember 13, 2021
Alternatives Channel Duff & Phelps Introduces Actively Managed Clean Energy ETF, ‘VCLN’ By Aaron NeuwirthAugust 4, 2021
ETF Building Blocks Channel Will the Biotech Space Consolidate in the Back Half of the Year? By Tom LydonJuly 14, 2021
Alternatives Channel ETFs that Could Benefit from Biden’s Infrastructure Plan By Ian YoungJuly 8, 2021
ETF Building Blocks Channel Post-Pandemic Healthcare Could Feature More Biotech M&A By Tom LydonJune 10, 2021
ETF Building Blocks Channel As Biotech Consolidation Heats up, ‘SBIO’ Could Be a Winner By Tom LydonMay 24, 2021
Alternatives Channel Active Municipal Bond ETFs: A Rare, Overlooked Asset Class By Tom LydonMay 24, 2021